96
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment

, , &
Pages 149-155 | Published online: 08 Aug 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Wanaporn Charoenchokthavee, Nutthada Areepium, Duangchit Panomvana & Virote Sriuranpong. (2017) Effects of CYP2D6 and CYP3A5 polymorphisms on tamoxifen and its metabolites in Thai breast cancer patients. Breast Cancer: Targets and Therapy 9, pages 249-256.
Read now

Articles from other publishers (1)

Anna Mueller-Schoell, Robin Michelet, Lena Klopp-Schulze, Madelé van Dyk, Thomas E. Mürdter, Matthias Schwab, Markus Joerger, Wilhelm Huisinga, Gerd Mikus & Charlotte Kloft. (2021) Computational Treatment Simulations to Assess the Need for Personalized Tamoxifen Dosing in Breast Cancer Patients of Different Biogeographical Groups. Cancers 13:10, pages 2432.
Crossref